RxDoctor Payments DataLook up a doctor →

Robert Mohr, MD

Internal Medicine · Ogden, UTNPI 1750314480

Payments from drug & device makers

$6,725in general payments, 2019–2025

Across 401 payments — averaging $16.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$957
  • Amgen$856
  • Astellas Pharma US Inc$631
  • Amarin Pharma, Inc.$590
  • Lilly USA, LLC$455
  • Novo Nordisk$432
  • plus $3K from 50 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)67$957
Amgen31$856
Astellas Pharma US Inc35$631
Amarin Pharma, Inc.55$590
Lilly USA, LLC31$455
Novo Nordisk23$432
Otsuka America Pharmaceutical, Inc.17$252
Abbott9$199
Johnson & Johnson(2 entities)11$181
Pfizer8$173
Alkermes, Inc.8$152
Phathom Pharmaceuticals, Inc.7$150
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC8$137
AstraZeneca8$133
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)5$90
Biohaven Pharmaceutical Holding Company Ltd.4$82
Sumitomo Pharma America, Inc.4$72
Novartis4$67
Takeda Pharmaceuticals U.S.A., Inc.2$63
Exact Sciences4$62
Merck4$58
Dexcom, Inc.3$58
GSK3$54
Sanofi-aventis U.S. LLC3$53
Dynavax Technologies Corporation3$48
Lundbeck LLC2$46
Grifols USA, LLC2$46
Strongbridge US Inc.3$45
Edwards Lifesciences2$39
Eisai Inc.3$37
Biohaven Pharmaceuticals, Inc.3$35
Bayer2$34
Biogen2$32
Sanofi Pasteur Inc.2$29
Baxter Healthcare1$26
E.r. Squibb & Sons, L.L.C.2$25
Bausch & Lomb Americas Inc.1$23
Treace Medical Concepts, Inc.1$23
Nestle Healthcare Nutrition Inc.1$20
Phadia US Inc.1$19
Kowa Pharmaceuticals America, Inc.1$18
Inspire Medical Systems, Inc.1$18
Xeris Pharmaceuticals, Inc.1$17
Hologic Sales And Service, LLC1$17
Verity Pharmaceuticals Inc.1$17
Axsome Therapeutics, Inc.1$16
Otsuka Pharmaceutical Development & Commercialization, Inc.1$16
Acadia Pharmaceuticals Inc1$15
Vertex1$15
Electromed, Inc.1$15
Teva Pharmaceuticals USA, Inc.1$14
Lucid Diagnostics Inc.1$14
Collegium Pharmaceutical, Inc.1$14
MDD US Operations, LLC1$12
Medtronic1$12
Biodelivery Sciences International, Inc.1$11

How this compares

$6,725 in reported general payments places this provider in the 85th percentile of 496 internal medicine providers in Utah.

See all internal medicine providers in Utah →

Medicare billing

Part B allowed, 2024
$140,113
Medicare patients
352
Services billed
2,551

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Ogden

See the full list for Utah →

Where these figures come from

Is this you, or does something look wrong? →